Effect of heterologous combination on competitive nephelometric immunoassay. II. Bridge-heterologous combination for ethosuximide immunoassay.
- 1 January 1984
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 32 (12) , 4958-4962
- https://doi.org/10.1248/cpb.32.4958
Abstract
We developed a competitive nephelometric immunoassay for the determination of ethosuximide. The method was based on the inhibition of immunoprecipitation by a hapten. Each of two ethosuximide derivatives, ethosuximide acetic acid and ethosuximide butyric acid, was conjugated to bovine serum albumin. These conjugates were injected into rabbits to raise anti-ethosuximide antisera. Each derivative was also conjugated to human serum albumin. These two conjugates were allowed to react with the two antisera in combination to form precipitates. Ethosuximide and its derivatives quantitatively inhibited these four precipitation reactions. The results indicated that the anti-(ethosuximide butyrate) antiserum recognized the bridge moiety better than the anti-(ethosuximide acetate) antiserum. Of the four combinations, the heterologous combination of the anti-(ethosuximide butyrate) antiserum with the (ethosuximide acetyl)-human serum albumin conjugate gave the most sensitive immunoassay for ethosuximide.Keywords
This publication has 4 references indexed in Scilit:
- Effect of heterologous combination on competitive nephelometric immunoassay. I. Site-heterologous combination for theophylline immunoassay.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Competitive nephelometric immunoassay of carbamazepine and its epoxide metabolite in patient blood plasma.Journal of Pharmacobio-Dynamics, 1981
- Competitive nephelometric immunoassay method for antiepileptic drugs in patient bloodJournal of Immunological Methods, 1979
- Competitive nephelometric immunoassay of theophylline in plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1979